# Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation

> **NCT02137213** · PHASE2 · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 20 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Naloxone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02137213
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137213, "Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02137213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*